Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-29

Clinical Trial Update: Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations

View source ↗

Summary

MiMARK Diagnostics is recruiting for a study evaluating a non-invasive in vitro diagnostic test for screening endometrial cancer in high-risk populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: MiMARK Diagnostics, S.L. | Conditions: Endometrial Cancer | Status: RECRUITING